70 related articles for article (PubMed ID: 1468210)
1. Mycobacterium fortuitum keratitis. Clinicopathologic correlates and corticosteroid effects in an animal model.
Paschal JF; Holland GN; Sison RF; Berlin OG; Bruckner DA; Dugel PU; Foos RY
Cornea; 1992 Nov; 11(6):493-9. PubMed ID: 1468210
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium fortuitum keratitis. A comparison of topical ciprofloxacin and amikacin in an animal model.
Stevens RK; Holland GN; Paschal JF; Phinney RB; Berlin OG; Bruckner DA
Cornea; 1992 Nov; 11(6):500-4. PubMed ID: 1468211
[TBL] [Abstract][Full Text] [Related]
3. Age-related differences in rabbits during experimental Staphylococcus aureus keratitis.
O'Callaghan RJ; McCormick CC; Caballero AR; Marquart ME; Gatlin HP; Fratkin JD
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5125-31. PubMed ID: 17962465
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
Caballero AR; Marquart ME; O'Callaghan RJ; Thibodeaux BA; Johnston KH; Dajcs JJ
Curr Eye Res; 2006 Jan; 31(1):23-9. PubMed ID: 16421016
[TBL] [Abstract][Full Text] [Related]
5. Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy.
Brockman EB; Tarantino PA; Hobden JA; Hill JM; O'Callaghan RJ; Kaufman HE; Insler MS
Refract Corneal Surg; 1992; 8(1):39-43. PubMed ID: 1554638
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
Oguz H; Ozbilge H; Oguz E; Gurkan T
Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
[TBL] [Abstract][Full Text] [Related]
7. Effect of amniotic membrane transplantation on the healing of bacterial keratitis.
Barequet IS; Habot-Wilner Z; Keller N; Smollan G; Ziv H; Belkin M; Rosner M
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):163-7. PubMed ID: 18172088
[TBL] [Abstract][Full Text] [Related]
8. Staphylococcus corneal virulence in a new topical model of infection.
Hume EB; Dajcs JJ; Moreau JM; Sloop GD; Willcox MD; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2904-8. PubMed ID: 11687535
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic lamellar keratectomy in the management of nontuberculous Mycobacterium keratitis refractory to medical treatments.
Tseng SH; Hsiao WC
Cornea; 1995 Mar; 14(2):161-6. PubMed ID: 7743799
[TBL] [Abstract][Full Text] [Related]
10. Nontuberculous mycobacterial keratitis in south Florida.
Ford JG; Huang AJ; Pflugfelder SC; Alfonso EC; Forster RK; Miller D
Ophthalmology; 1998 Sep; 105(9):1652-8. PubMed ID: 9754173
[TBL] [Abstract][Full Text] [Related]
11. Contact lens-induced infection--a new model of Candida albicans keratitis.
O'Day DM; Head WS; Robinson RD; Yang R; Shetlar D; Wang MX
Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1607-11. PubMed ID: 10359345
[TBL] [Abstract][Full Text] [Related]
12. Effect of vitamin A deficiency on the early response to experimental Pseudomonas keratitis.
Twining SS; Zhou X; Schulte DP; Wilson PM; Fish B; Moulder J
Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):511-22. PubMed ID: 8595951
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of topical ciprofloxacin for treating Mycobacterium fortuitum and Mycobacterium chelonae keratitis in an animal model.
Lin R; Holland GN; Helm CJ; Elias SJ; Berlin OG; Bruckner DA
Am J Ophthalmol; 1994 May; 117(5):657-62. PubMed ID: 8172274
[TBL] [Abstract][Full Text] [Related]
14. [Experimental study of non-tuberculous mycobacterial keratitis in rabbits].
Liang QF; Wang ZQ; Deng SJ; Li R; Luo SY; Sun XG
Zhonghua Yan Ke Za Zhi; 2007 Jul; 43(7):613-7. PubMed ID: 17897550
[TBL] [Abstract][Full Text] [Related]
15. Effect of hybrid peptides of cecropin A and melittin in an experimental model of bacterial keratitis.
Nos-Barbera S; Portoles M; Morilla A; Ubach J; Andreu D; Paterson CA
Cornea; 1997 Jan; 16(1):101-6. PubMed ID: 8985641
[TBL] [Abstract][Full Text] [Related]
16. Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model.
Helm CJ; Holland GN; Lin R; Berlin OG; Bruckner DA
Am J Ophthalmol; 1993 Dec; 116(6):700-7. PubMed ID: 8250072
[TBL] [Abstract][Full Text] [Related]
17. Nona-D-arginine therapy for Pseudomonas aeruginosa keratitis.
Karicherla P; Hobden JA
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):256-62. PubMed ID: 18775859
[TBL] [Abstract][Full Text] [Related]
18. Effects of toxin production in a murine model of Staphylococcus aureus keratitis.
Girgis DO; Sloop GD; Reed JM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2064-70. PubMed ID: 15914624
[TBL] [Abstract][Full Text] [Related]
19. Effect of systemic tetracycline on progression of Pseudomonas aeruginosa keratitis in the rabbit.
Levy JH; Katz HR
Ann Ophthalmol; 1990 May; 22(5):179-83. PubMed ID: 2114813
[TBL] [Abstract][Full Text] [Related]
20. The protective role of topical propolis on experimental keratitis via nitric oxide levels in rabbits.
Duran N; Koc A; Oksuz H; Tamer C; Akaydin Y; Kozlu T; Celik M
Mol Cell Biochem; 2006 Jan; 281(1-2):153-61. PubMed ID: 16328968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
